Market Place
Sourcing Support
All News #Library
Biotech
LB Pharma Presents At 25Th Needham Healthcare Conference
09 Apr 2026 //
GLOBENEWSWIRE
LB Pharma Presents NOVA-1 LB-102 Cognition Data at SIRS Society
27 Mar 2026 //
GLOBENEWSWIRE
LB Pharma Starts Pivotal Ph 3 Trial of LB-102 in Schizophrenia
25 Mar 2026 //
GLOBENEWSWIRE
LB Pharma Joins March Investor Conference
04 Mar 2026 //
GLOBENEWSWIRE
Psychedelic Biotechs Advance CNS Treatments To Phase 3
27 Feb 2026 //
PR NEWSWIRE
LB Pharma Launches Phase 2 ILLUMINATE-1 Trial for LB-102
26 Jan 2026 //
GLOBENEWSWIRE
LB Pharma Names Minako Pazdera, J.D., Ph.D. General Counsel
21 Jan 2026 //
GLOBENEWSWIRE
LB Pharma, Celldex Hire Commercial Heads As Launch Plans Ramp Up
14 Nov 2025 //
FIERCE PHARMA
LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress
06 Oct 2025 //
GLOBENEWSWIRE
Neuroscience Biotech LB Files $228M IPO for Phase III Plans
09 Sep 2025 //
BIOSPACE
LB Pharmaceuticals Targets $228M IPO Cash
08 Sep 2025 //
FIERCE BIOTECH
LB Pharma`s twist on old Sanofi drug passes schizophrenia test
09 Jan 2025 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.